Skip to main content
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.350
-0.020 (-1.46%)
Feb 21, 2025, 4:00 PM EST - Market closed

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $16.22M in the quarter ending December 31, 2024, a decrease of -13.48%. This brings the company's revenue in the last twelve months to $77.23M, down -14.22% year-over-year. In the fiscal year ending June 30, 2024, Aytu BioPharma had annual revenue of $81.00M, down -24.58%.

Revenue (ttm)
$77.23M
Revenue Growth
-14.22%
P/S Ratio
0.10
Revenue / Employee
$757,176
Employees
102
Market Cap
8.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202481.00M-26.40M-24.58%
Jun 30, 2023107.40M10.73M11.10%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 202027.63M20.31M277.47%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

AYTU News

More News